1DR9 image
Entry Detail
PDB ID:
1DR9
Keywords:
Title:
CRYSTAL STRUCTURE OF A SOLUBLE FORM OF B7-1 (CD80)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2000-01-06
Release Date:
2000-01-10
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.28
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
I 41 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:T LYMPHOCYTE ACTIVATION ANTIGEN
Chain IDs:A
Chain Length:201
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Ligand Molecules
Primary Citation
Structure and dimerization of a soluble form of B7-1.
Immunity 12 51 60 (2000)
PMID: 10661405 DOI: 10.1016/S1074-7613(00)80158-2

Abstact

B7-1 (CD80) and B7-2 (CD86) are glycoproteins expressed on antigen-presenting cells. The binding of these molecules to the T cell homodimers CD28 and CTLA-4 (CD152) generates costimulatory and inhibitory signals in T cells, respectively. The crystal structure of the extracellular region of B7-1 (sB7-1), solved to 3 A resolution, consists of a novel combination of two Ig-like domains, one characteristic of adhesion molecules and the other previously seen only in antigen receptors. In the crystal lattice, sB7-1 unexpectedly forms parallel, 2-fold rotationally symmetric homodimers. Analytical ultracentrifugation reveals that sB7-1 also dimerizes in solution. The structural data suggest a mechanism whereby the avidity-enhanced binding of B7-1 and CTLA-4 homodimers, along with the relatively high affinity of these interactions, favors the formation of very stable inhibitory signaling complexes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures